Investors
Bioxodes is a Belgian private company, founded in 2010. The Company has received fundings from both public and private investors.
Investors
Public & private investors
Private Equity
(Euros)
Grants/subsidies from the Walloon Region
(Euros)
Investors
Who invests?
Investors
Why invest?
-
First-in-class lead compound with solid preclinical and Phase I clinical data.
-
Discovery program for innovative pipeline to extend value capture beyond thrombo-inflammation.
-
Leadership and expertise with international advisor network.
-
Patent portfolio wholly owned with coverage beyond 2040.
Investors
Invest in us
Get in touch and explore our investment opportunities
investment@bioxodes.com